Yasons Chemex

When is the next results date for Yasons Chemex?

No Upcoming Board Meetings

Has Yasons Chemex declared dividend?

No Dividend History Available

What is the technical trend for Yasons Chemex?

As of June 6, 2025, Yasons Chemex shows a mildly bearish trend, with mixed signals from indicators like MACD and KST, while moving averages remain bearish.

As of 6 June 2025, the technical trend for Yasons Chemex has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the daily moving averages remain bearish. The Bollinger Bands are showing a mildly bearish trend on both weekly and monthly time frames. The KST is mildly bullish on the weekly, but the OBV is bearish for both weekly and monthly periods. Overall, the current technical stance is mildly bearish, driven primarily by the bearish moving averages and the mixed signals from MACD and KST.

Who are the peers of the Yasons Chemex?

Yasons Chemex's peers include Bodal Chemicals, Bhageria Industries, Asahi Songwon, and others, with varying management risks and growth rates. Yasons Chemex has a below-average management risk and a 1-year return of -48.67%, lower than its peers.

Peers: The peers of Yasons Chemex are Bodal Chemicals, Bhageria Indust., Asahi Songwon, Poddar Pigments, AksharChem (I), Ducol Organics, Hindprakash Indu, Siddhika Coatins, Prolife Indust., and Arunaya Organics.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bhageria Indust., Poddar Pigments, AksharChem (I), Prolife Indust., and Arunaya Organics, while Average management risk is found at Asahi Songwon, Ducol Organics, Hindprakash Indu, Siddhika Coatins, and the rest. Below Average management risk is noted at Bodal Chemicals and Yasons Chemex. In terms of Growth, Average growth is seen at Arunaya Organics, while Below Average growth is present at Bodal Chemicals, Bhageria Indust., Asahi Songwon, Poddar Pigments, AksharChem (I), Ducol Organics, Hindprakash Indu, Siddhika Coatins, Prolife Indust., and Yasons Chemex. For Capital Structure, Excellent capital structure is noted at Bhageria Indust., Poddar Pigments, and AksharChem (I), Good capital structure is found at Ducol Organics and Siddhika Coatins, while Below Average capital structure is observed at Bodal Chemicals, Asahi Songwon, Hindprakash Indu, Prolife Indust., and Yasons Chemex.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Bhageria Indust. at 22.12%, while the peer with the lowest 1-year return is Poddar Pigments at -30.64%. Yasons Chemex's 1-year return of -48.67% is lower than both of these peers. Additionally, Ducol Organics, Hindprakash Indu, Prolife Indust., and Arunaya Organics have negative six-month returns.

What does Yasons Chemex do?

Yasons Chemex Care Ltd manufactures dyes, pigment paste, and FMCG products, classified as a Micro Cap company with a market cap of INR 24 Cr. It was incorporated in 2017 and has a P/E ratio of 15.00, with no recent sales or profit data available.

Overview: <BR>Yasons Chemex Care Ltd is engaged in the manufacturing of dyes and pigment paste, as well as FMCG products, operating within the Dyes and Pigments industry and classified as a Micro Cap company.<BR><BR>History: <BR>Yasons Chemex Care Ltd was incorporated on October 17, 2017, in Ahmedabad. There are no reported status changes, and revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 24 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 15.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.18 <BR>Return on Equity: 4.12% <BR>Price-to-Book: 0.62 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the top shareholders of the Yasons Chemex?

The top shareholders of Yasons Chemex are Yash Chemex Limited with 51.47%, followed by public shareholder Lakhani Jignesh Jasmatbhai (HUF) at 3.38%. Individual investors hold a collective 40.1%, with no mutual funds or foreign institutional investors involved.

The top shareholders of Yasons Chemex include Yash Chemex Limited, which holds the largest stake at 51.47%. This makes it the primary promoter of the company. Additionally, the highest public shareholder is Lakhani Jignesh Jasmatbhai (HUF), who owns 3.38%. Individual investors collectively hold 40.1% of the shares. There are currently no mutual funds or foreign institutional investors involved in the company's shareholding.

How big is Yasons Chemex?

As of 23rd July, Yasons Chemex Care Ltd has a market capitalization of 24.00 Cr, classified as a Micro Cap, with no valid financial data available for Net Sales and Net Profit for the latest four quarters. The balance sheet as of March 2024 shows Shareholder's Funds of 39.08 Cr and Total Assets of 54.50 Cr.

As of 23rd July, <BR><BR>Market Cap: Yasons Chemex Care Ltd has a market capitalization of 24.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 39.08 Cr and Total Assets totaling 54.50 Cr.

How has been the historical performance of Yasons Chemex?

Yasons Chemex has experienced significant revenue growth, with net sales increasing from 36.77 Cr in Mar'22 to 76.53 Cr in Mar'25. However, profitability has declined, with profit after tax falling from 3.43 Cr in Mar'23 to 1.62 Cr in Mar'25, and cash flow from operations remaining negative.

Answer:<BR>The historical performance of Yasons Chemex shows a fluctuating trend in key financial metrics over the past four years.<BR><BR>Breakdown:<BR>Yasons Chemex's net sales have increased from 36.77 Cr in Mar'22 to 76.53 Cr in Mar'25, indicating significant growth. Total operating income mirrored this trend, rising from 36.77 Cr in Mar'22 to 76.53 Cr in Mar'25. However, total expenditure also rose, from 36.28 Cr in Mar'22 to 75.27 Cr in Mar'25, leading to an operating profit (PBDIT) that peaked at 4.72 Cr in Mar'23 but fell to 4.04 Cr by Mar'25. Profit before tax showed a decline from 4.21 Cr in Mar'23 to 2.23 Cr in Mar'25, while profit after tax decreased from 3.43 Cr in Mar'23 to 1.62 Cr in Mar'25. The company's total assets grew from 27.57 Cr in Mar'23 to 59.29 Cr in Mar'25, alongside an increase in total liabilities from 27.57 Cr to 59.29 Cr during the same period. Cash flow from operating activities remained negative, with a notable outflow of 2.00 Cr in Mar'25, contrasting with a positive inflow of 1.00 Cr in Mar'24. Overall, while Yasons Chemex has seen revenue growth, profitability and cash flow have faced challenges in recent years.

Is Yasons Chemex overvalued or undervalued?

As of November 18, 2025, Yasons Chemex is considered overvalued with a PE ratio of 14.81 and an EV to EBITDA ratio of 28.09, especially when compared to peers like Godrej Industries and Deepak Nitrite, and has underperformed the Sensex with a year-to-date return of -36.01%.

As of 18 November 2025, Yasons Chemex has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE ratio of 14.81, an EV to EBITDA ratio of 28.09, and a PEG ratio of 0.51, which indicates that despite a low PEG, the overall valuation appears excessive relative to its earnings growth potential.<BR><BR>In comparison to its peers, Yasons Chemex's valuation stands out as expensive, especially when juxtaposed with Godrej Industries, which is rated attractive with a PE of 37.03, and Deepak Nitrite, also expensive with a PE of 43.74. Furthermore, Yasons Chemex's recent stock performance has lagged significantly behind the Sensex, with a year-to-date return of -36.01% compared to the Sensex's 9.58%, reinforcing the notion of overvaluation in the current market context.

Which are the latest news on Yasons Chemex?

Why is Yasons Chemex Care Ltd falling/rising?

As of 10-Apr, Yasons Chemex Care Ltd's stock price is at 10.10, unchanged from the previous session, with a year-to-date decline of 24.34%. The stock is underperforming its sector and has seen decreased investor participation, indicating ongoing downward pressure.

As of 10-Apr, Yasons Chemex Care Ltd's stock price is currently at 10.10, showing no change from the previous trading session. The stock has experienced a significant decline over the year, with a year-to-date drop of 24.34% and a one-year decrease of 29.62%. This underperformance is starkly contrasted with the Sensex, which has gained 7.37% over the same period.<BR><BR>In the short term, the stock has underperformed its sector by 1.19% today. Additionally, the stock's moving averages indicate a mixed performance; while it is higher than the 5-day and 20-day moving averages, it remains lower than the 50-day, 100-day, and 200-day moving averages, suggesting a lack of upward momentum. <BR><BR>Investor participation has also declined, with a delivery volume of 6,000 shares on April 9, which is a 41.18% decrease compared to the 5-day average. This drop in trading activity may indicate waning interest among investors, contributing to the stock's struggles. Overall, the combination of poor long-term performance, underwhelming short-term results, and falling investor participation suggests that Yasons Chemex Care Ltd is currently facing downward pressure on its stock price.